David Lee, MD

Professor of Medicine (Cardiovascular Medicine)

Clinical Focus

Cardiology (Heart)
Interventional Cardiology

Academic Appointments

Professor - University Medical Line, Medicine - Cardiovascular Medicine
Member, Cardiovascular Institute

Administrative Appointments

Director, Interventional Cardiology Fellowship Program, Stanford University Medical Center (2005 - Present)
Director, Interventional Platform/Cardiac Catheterization and Intervention Laboratories, Stanford University Medical Center (2007 - Present)

Boards, Advisory Committees, Professional Organizations

Member, California State STEMI and Stroke Technical Advisory Committee (2020 - Present)
President, Western States Affiliate, American Heart Association (2016 - 2020)

Professional Education

Medical Education: University of Minnesota School of Medicine (1992) MN
Fellowship: Stanford University Cardiovascular Medicine Fellowship (1998) CA
Residency: Stanford University Internal Medicine Residency (1995) CA
M.D., University of Minnesota, Medicine (1992)
S.B, M.I.T., Biology (1987)

Contact

Academic dplee@stanford.edu Tel: (650) 725-2621 Fax: (650) 725-6766

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Cardiovascular Medicine 300 Pasteur Dr Rm A260 MC 5319 Stanford CA 94305 Tel: (650) 723-6459 Fax: (650) 723-8392

Additional Clinical Info

Stanford Health Care

Current Research and Scholarly Interests

1. Novel treatments and devices for the treatment of valvular disease
2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
3. Novel approaches to coronary revascularization
4. Closure devices for atrial septal defects and patent foramen ovale
5. Novel treatments for hypertension

Clinical Trials

SPYRAL DYSTAL Renal Denervation Global Clinical Study Not Recruiting
More
The objective of this single arm interventional study is to determine if renal denervation performed in the distal main and first order branch renal arteries is as effective in reducing blood pressure as the procedural approach used in the SPYRAL HTN-OFF MED clinical study.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- David Lee, MD
View full details
Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects Recruiting
More
The objective of this early feasibility study is to evaluate the safety and performance of intravascular hepatic denervation using the Metavention Integrated Radio Frequency Denervation System (iRF System) to improve glycemic control in type 2 diabetes subjects.
Lead Sponsor
Stanford Investigators
View full details
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Not Recruiting
More
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
View full details
Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension Not Recruiting
More
The purpose of this study is to assess the effectiveness of a multi-gene panel to determine which subjects are likely to respond to renal denervation therapy with Medtronic's Symplicity Spyral™ multi-electrode renal denervation system.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- David Lee, MD
View full details
A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) Recruiting
More
The purpose of this trial is to evaluate the clinical safety and effectiveness of the Resolute Onyx stent in subjects deemed at high risk for bleeding and/or medically unsuitable for more than 1 month DAPT treatment receiving reduced duration (1 month) of DAPT following stent implantation.
Lead Sponsor
Stanford Investigators
- David Lee, MD
View full details
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial Recruiting
More
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)
Lead Sponsor
Stanford Investigators
View full details
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. Recruiting
More
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Lead Sponsor
Stanford Investigators
View full details
2019-06 TRISCEND Study Recruiting
More
Prospective, multi-center study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
Lead Sponsor
Stanford Investigators
View full details
SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System Recruiting
More
The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the presence of up to three standard antihypertensive medications.
Lead Sponsor
Stanford Investigators
- Alan Yeung, MD
- David Lee, MD
View full details
SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study Recruiting
More
The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the absence of antihypertensive medications.
Lead Sponsor
Stanford Investigators
- Alan Yeung, MD
- David Lee, MD
View full details
AMPLATZER PFO Occluder Post Approval Study Recruiting
More
The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.
Lead Sponsor
Stanford Investigators
- David Lee, MD
View full details

2023-24 Courses

Independent Studies
- Directed Reading in Medicine
  MED 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience in Medicine
  MED 280 (Aut, Win, Spr, Sum)
- Graduate Research
  MED 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  MED 370 (Aut, Win, Spr, Sum)
- Undergraduate Research
  MED 199 (Aut, Win, Spr, Sum)

Graduate and Fellowship Programs

All Publications

Profiles With Related Publications

close
Hans-Christoph Becker, MD, FSABI, FSCCT

Clinical Professor, Radiology
Clinical Focus
Diagnostic Radiology
Research Interests
Myocardial bridges (MB) with associated upfront atherosclerotic lesions are common findings on coronary computed tomography angiography (CTA). Abnormal septal wall motion in exercise echocardiography (EE) may to be associated with MB. Intravascular ultrasound (IVUS) is considered the gold standard for the detection of MB. We investigate whether CTA is comparable to IVUS for the assessment of MB and upstream plaques in symptomatic patients with suspicion for MB raised by EE.

243 Total Publications
close
Todd Brinton

Adjunct Professor, Medicine - Cardiovascular Medicine

40 Total Publications
close
William Fearon, MD

Professor of Medicine (Cardiovascular Medicine)
Clinical Focus
Interventional Cardiology, Transcatheter aortic valve replacement, TAVR, Percutaneous Coronary Intervention, Aortic Stenosis, Coronary Artery Disease, Coronary Physiology
Research Interests
Dr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.

520 Total Publications
close
Dominik Fleischmann

Professor of Radiology (Cardiovascular Imaging)
Clinical Focus
Cardiovacular Imaging, Diagnostic Radiology, Radiology
Research Interests
Non-invasive Cardiovascular Imaging
Image Post-processing
Contrast Medium Dynamics

300 Total Publications
close
Victor Froelicher, MD

Professor of Medicine (Cardiovascular) at the Veterans Affairs Palo Alto Health Care System, Emeritus
Research Interests
Screening of athletes for sudden cardiac death, Computerized ECG and clinical data management; exercise Physiology including expired gas analysis; the effect of chronic and acute exercise on the heart; digital recording of biological signals; diagnostic use of exercise testing; development of Expert Medical System software and educational tools.

545 Total Publications
close
Francois Haddad

Clinical Professor, Medicine - Cardiovascular Medicine
Clinical Focus
RIght Heart Failure, Pulmonary Hypertension, Hypertensive Heart Disease, Heart Failure with preserved ejection fraction, Advanced heart failure, Heart Transplantation, Unexplained Dyspnea, Mechanical Cardiac Support, Advanced Heart Failure and Transplant Cardiology

345 Total Publications
close
Robert Harrington

Arthur L. Bloomfield Professor of Medicine, Emeritus

726 Total Publications
close
Paul Heidenreich, MD

Professor of Medicine (Cardiovascular)
Clinical Focus
Echocardiography, Cardiovascular Disease
Research Interests
My research interests include

1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.

2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.

3) Outcomes research using existing clinical and administrative datasets.

4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).

936 Total Publications
close
Mark Hlatky, MD

Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Research Interests
My main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.

423 Total Publications
close
Yasuhiro Honda, MD

Clinical Professor, Medicine - Cardiovascular Medicine

524 Total Publications
close
Sharon Hunt, MD

Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center, Emerita

224 Total Publications
close
Fumiaki Ikeno

Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine

144 Total Publications